Why does AI governance need industry-specific overlays?

Industry-specific AI governance overlays exist because regulated sectors impose controls a generic framework does not cover. Banking adds model risk and fair-lending rules. Healthcare adds PHI boundaries. Gaming adds responsible gambling triggers.

The base framework stays constant. The overlay changes by sector and jurisdiction. A model registry, a HITL review queue, and an incident log work the same way in every industry. What changes is the named regulator, the reporting cadence, and the evaluation criteria.

What does AI governance look like in BFSI?

BFSI AI governance follows US SR 11-7 model risk management, OCC 2013-29 / 2023-17, Reg B and ECOA fair lending, FCRA adverse-action accuracy, AML and OFAC screening, and SOX auditability. NAIC Model AI Bulletin and NY DFS Circular Letter No. 7 add insurer and state-level expectations.

Colorado AI Act, Utah AI Policy Act, and Texas TRAIGA layer state consumer-protection rules on top. EU-facing units add DORA for ICT third-party risk and the EU AI Act for high-risk credit and insurance systems. Indian banks map to RBI AI/ML guidance and DPDP. UAE units reference CBUAE and DIFC. Singapore lenders apply MAS FEAT and Notice 655. Canadian banks follow OSFI E-23.

What does AI governance look like in healthcare?

Healthcare AI governance starts with HIPAA Privacy, Security, and Breach Notification rules, HITECH, HITRUST CSF, 42 CFR Part 2 for substance-use records, and FDA SaMD guidance with Predetermined Change Control Plans for adaptive models. State privacy laws add CMIA, NY SHIELD, and CCPA / CPRA health-data rules.

EU operations layer GDPR special-category protections and the EU AI Act for clinical decision support. India treats health data as sensitive personal data under DPDP. UAE providers follow DIFC Data Protection Law and Dubai Health Authority rules. Singapore uses PDPA and the HealthTech Instrument. Canadian providers map to PIPEDA, PHIPA in Ontario, and HIA in Alberta.

What does AI governance look like in casino gaming and hospitality?

Casino AI governance addresses Title 31 BSA reporting, FinCEN MSB obligations, and state gaming commission rules from Nevada GCB, NJ DGE, Pennsylvania PGCB, and Michigan MGCB. The American Gaming Association responsible gambling framework guides intervention thresholds and guest data isolation across player analytics, AML, and loyalty systems.

Operators with EU guests apply GDPR and the EU AI Act where biometric surveillance or consequential decisions apply. Singapore licensees follow the Casino Control Act and PDPA. UK operations map to the Gambling Commission. Macau properties reference DICJ guidance. Dubai’s GCGRA sets the baseline for new UAE licensees.

What belongs in every overlay regardless of industry?

Every overlay needs three elements: a named regulator mapped to specific controls, a sector-specific incident reporting cadence, and domain-trained model evaluation criteria. Without those three, the overlay is a label, not a control.

Map each control to the regulator that asks for it. Define the reporting clock for that regulator, whether it is HHS OCR breach notification, FinCEN SAR timing, or state gaming commission incident windows. Then build evaluation criteria that reflect the domain: fair-lending fairness tests for credit, clinical accuracy for diagnosis, and intervention-trigger precision for responsible gambling.

What to do next

List every AI system in scope, tag each with its primary regulator, and confirm that the incident reporting cadence and evaluation criteria match what that regulator expects. Anything missing is a gap in your overlay.

Read next: Enterprise AI Governance Framework

The post Industry-Specific AI Governance: BFSI, Healthcare, Gaming appeared first on Data, AI, Automation & Enterprise App Delivery with a Quality-First Partner.

Healthcare AI hits three walls before it reaches production: FDA clearance requirements, HIPAA constraints on training data, and EHR integration friction with Epic and Cerner. AI implementation healthcare is harder than other verticals. Not because the models are worse, but because the governance layer is thicker. Organizations that treat these as pure engineering problems stall at the pilot stage.

What FDA clearance requirements apply to healthcare AI software?

Any AI software that meets the FDA’s definition of Software as a Medical Device (SaMD) requires 510(k) clearance or De Novo authorization before clinical use, regardless of whether it makes a diagnosis directly.

The FDA has cleared over 1,250 AI-enabled medical devices as of July 2025. Of those, 671 are in radiology. That concentration isn’t accidental. Radiology was the first specialty to produce large, structured, labeled datasets at scale. Other specialties are catching up, but the regulatory backlog is real.

In January 2025, the FDA issued draft guidance on lifecycle management for AI-enabled device software. The December 2024 guidance on Predetermined Change Control Plans (PCCP) lets manufacturers pre-specify how models may change post-market without resubmission. But most health systems need to verify clearance status before deploying third-party tools like Aidoc or Viz.ai. Aidoc, deployed in 900+ hospitals, received FDA clearance for rib fracture CADt in February 2025. Clinical studies attribute a 26% reduction in CT turnaround time to its use. A custom-built in-house model carries no such clearance by default.

Can you use patient data to train AI models under HIPAA?

Protected health information (PHI) can be used for AI model training under HIPAA’s “healthcare operations” provisions without patient authorization, but de-identification must meet Safe Harbor or Expert Determination standards.

Safe Harbor requires stripping 18 specific data identifiers. This often degrades the clinical richness that makes training data valuable. Expert Determination requires a qualified statistician to certify that re-identification risk is very small. Both paths slow development cycles.

A January 2025 HHS proposed rule would bring ePHI used in AI training under the HIPAA Security Rule. Security and legal teams should treat that rule as coming, even without finalization. Tempus, which went public in 2024, built its cancer genomics dataset around compliant data partnerships with health systems. That model works at scale. But it took years to build.

If your organization is preparing data infrastructure for AI, the groundwork matters. See AI data readiness: what enterprises need to fix before scaling AI models for the broader enterprise framing.

Why is EHR integration the hardest part of healthcare AI deployment?

EHR integration is the hardest part of healthcare AI deployment because Epic and Cerner control data access through proprietary ecosystems, and 70% of hospitals cite integration as their top AI adoption barrier.

HL7 FHIR was supposed to solve this. It helps, but 84% of hospitals using FHIR APIs still report seamless data exchange as a challenge. The reasons: inconsistent implementation and security concerns. Epic’s App Orchard marketplace offers a path for vetted vendors, but it’s a closed ecosystem. In 2025, Particle Health and CureIS Healthcare filed antitrust claims against Epic over its data practices. Those cases are ongoing.

Nuance DAX, Microsoft’s ambient clinical documentation AI, plugged directly into Epic workflows. Peer-reviewed cohort studies show it cuts documentation time by roughly 50%, saving up to 7 minutes per encounter. That worked because Microsoft had the leverage to build a deep EHR partnership. Most vendors don’t. If your AI tool needs a custom integration build, budget 3-6 months of engineering time before you see clinical value.

What healthcare AI use cases have actually reached production?

Radiology triage, ambient clinical documentation, and precision medicine are the three use cases where healthcare AI has the most validated, FDA-cleared production deployments at enterprise scale.

Only 18% of healthcare organizations are ready to deploy AI in care delivery, according to Menlo Ventures’ 2025 report. Yet 85% have explored it. The gap is governance, not technology. HL7 launched an AI Office in July 2025 and hired its first Chief AI Officer to address interoperability. But standards take time. Your deployment timeline should not assume they are solved.

For the governance framework that sits above all three of these walls, see how to build an AI governance framework for production deployment.

What to do next

Before committing to a healthcare AI vendor or building in-house, confirm three things. First, the tool’s FDA clearance status and SaMD classification. Second, the HIPAA data use agreement terms for model training. Third, the specific EHR integration pathway: App Orchard, FHIR API, or custom build. All three affect your go-live date more than the model itself.

Read next: What it actually takes to move AI from proof of concept to production

The post Enterprise AI Implementation in Healthcare appeared first on Data, AI, Automation & Enterprise App Delivery with a Quality-First Partner.